Everand Logo

Welcome to Everand!

  • STAT

    LISTEN: Using the word ‘cure,’ an FDA loophole, & making biotech history

    Can gene therapy cure sickle cell disease? Is an expensive drug better than a free one? And will biotech see its shadow in 2019? Find out in the latest episode…
    by Damian Garde and Rebecca Robbins and Adam Feuerstein Dec 06, 2018 1 minute

    Can gene therapy cure sickle cell disease? Is an expensive drug better than a free one? And will biotech see its

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min readChemistry
    STAT+: Pharmalittle: We’re Reading About Fake Studies, AbbVie Investing In Psychedelics, And More
    Fake studies have flooded publishers of top scientific journals,. leading to thousands of retractions and millions of dollars in lost revenue.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
    When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.
    STAT1 min read
    Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
    To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

    Related Books & Audiobooks